Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striatopallido-thalamic function

Behavioral and Brain Sciences - Tập 10 Số 2 - Trang 197-208 - 1987
Neal R. Swerdlow1, George F. Koob2
1Mercy Hospital and Medical Center, 4077 Fifth Ave., San Diego, Calif. 92103
2Division of Preclinical Neuroscience and Endocrinology, Scripps Clinic and Research Foundation, La Jolla, Calif. 92037 (Reprint requests should be sent to G. F. Koob.

Tóm tắt

AbstractConsiderable evidence from preclinical and clinical investigations implicates disturbances of brain dopamine (DA) function in the pathophysiology of several psychiatric and neurologic disorders. We describe a neural model that may help organize theseindependent experimental observations. Cortical regions classically associated with the limbic system interact with infracortical structures, including the nucleus accumbens, ventral pallidum, and dorsomedial nucleus of the thalamus. In our model, overactivity in forebrain DA systems results in the loss of lateral inhibitory interactions in the nucleus accumbens, causing disinhibition of pallidothalamic efferents; this in turn causes rapid changes and a loss of focused corticothalamic activity in cortical regions controlling cognitive and emotional processes. These effects might be manifested clinically by some symptoms of psychoses. Underactivity of forebrain DA results in excess lateral inhibition in the nucleus accumbens, causing tonic inhibition of pallidothalamic efferents; this perpetuates tonic corticothalamic activity and prevents the initiation of new activity in other critical cortical regions. These effects might be manifested clinically by some symptoms of depression. This model parallels existing explanations for the etiology of several movement disorders, and may lead to testable inferences regarding the neural substrates of specific psychopathologies.

Từ khóa


Tài liệu tham khảo

10.1007/BF00431680

10.1038/265645a0

Horn A. S. , & Snyder S. H. (1971) Chlorpromazine and dopamine: Conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs. Proceedings of the National Academy of Sdence, [JRS]

10.1111/j.1471-4159.1985.tb04013.x

Fouriezos, 1978, Decreased intracranial self-stimulation after neuroleptics: Mediation by reduced reward, not performance debilitation, Journal of Comparative Physiology and Psychology, 92, 659

Goodwin, 1973, A psychobiological approach to affective illness, Psychiatric Annals, 3, 19, 10.3928/0048-5713-19730201-05

Taghzouti K. , Simon H. , Hervé D. , Blanc G. , Studler J. M. , Glowinski J. , Le Moal M. & Tassin J. P. (submitted) Disturbances of motor and cognitive functions following lesions of the mesencephalic dopaminergic cell bodies are corrected by lesions of the dorsal noradrenergic ascending system. [JPT]

10.1016/0306-4522(85)90302-1

10.1017/S0317167100046230

10.1016/0006-8993(82)90283-9

10.1016/0006-8993(75)90834-3

10.1037/0033-2909.85.5.1001

10.1016/0006-8993(75)90205-X

10.1016/0006-8993(80)90559-4

10.1007/BF00235003

Widerlov, 1982, Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: Normalization after neuroleptic treatment, American Journal of Psychiatry, 139, 1122, 10.1176/ajp.139.9.1122

10.1007/BF00429012

10.1126/science.644310

Grace A. A. (1983) Nigral dopamine neurons: Identification, characterization, and effects of autoreceptor stimulation. Ph.D. dissertation, Yale University. [AAG]

Growden, 1982, Update III: Harrison's principles of internal medicine

10.1016/0006-8993(80)90896-3

10.1016/0024-3205(83)90165-0

Bird, 1979, Dopamine and homovanillic acid concentrations in postmortem brain in schizophrenia, Journal of Physiology, 293, 36

10.1016/0006-8993(79)90311-1

10.1016/0014-2999(83)90030-4

Post, 1980, Neurobiology of cerebrospinal fluid

10.1007/BF00427414

10.1016/0006-8993(85)90789-9

Beninger, 1983, Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning, Sdence, 220, 1304

Rylander, 1969, Abuse of central stimulants

10.1001/archpsyc.1978.01770290091008

Zaborszky, 1982, Afferents of the ventral pallidum studied with a combined immunohistochemical-anterograde degeneration method, Society of Neuroscience Abstracts, 8, 218

10.1016/0304-3940(84)90455-5

Kim, 1982, Psychobiology of schizophrenia

De Olmos, 1985, The rat nervous system, 1

10.1016/0006-8993(85)91385-X

Robinson T. G. & Beart P. M. (in press) Excitotoxic lesions reveal excitant amino acid projections to the nucleus accumbens septi from the basolateral nucleus of the amygdala and the parataenial nucleus of the thalamus in the rat. Neurosdence Letters. [PMB]

Parant, 1881, Paralysis agitans, 54

10.1001/archpsyc.1972.01750280030006

10.1016/0006-8993(85)90811-X

10.1097/00002826-198406001-00274

Weinberger, 1986, The neurology of schizophrenia

Knapp, 1974, Effects of amphetamine on regional tryptophan hydroxylase activity and synaptosomal conversion of tryptophan to 5-hydroxytryptamine in rat brain, Journal of Pharmacology and Experimental Therapy, 189, 676

10.1016/0165-0173(83)90005-X

10.1016/0006-8993(69)90003-1

10.1212/WNL.31.6.645

10.1001/archpsyc.1985.01790310046006

Willner, 1985, Depression: A psychobiological synthesis

Lotstra, 1984, No evidence of antipsychotic effect of caerulein in schizophrenic patients free of neuroleptics – a double-blind crossover study, Biological Psychiatry, 19, 877

10.1001/archpsyc.1975.01760210019001

10.1016/0006-8993(78)90059-8

10.1002/cne.901710305

10.1016/S0140-6736(77)91542-2

10.1016/0006-8993(84)90827-8

10.1016/0006-8993(75)90182-1

Winokur, 1982, Variability of hormonal responses to a series of neuroendocrine challenges (TRH, GnRH, ITT, DST) in depressed patients, American Journal of Psychiatry, 139, 39, 10.1176/ajp.139.1.39

10.1212/WNL.36.8.1130

Wolkin, 1984, Proceedings of the American College of Neuropsychology

10.1038/scientificamerican0783-70

10.1016/S0010-440X(65)80025-6

Gardner, 1980, Comparative effects of lithium on drug-induced and lesion-induced dopaminergic supersensitivity, Society of Neuroscience Abstracts, 6, 546

10.1016/0006-3223(85)90131-3

10.1037/0096-3445.105.1.3

10.1192/bjp.128.2.141

Weiss, 1982, Behavioral models and the analysis of drug action

10.1111/j.1471-4159.1986.tb00799.x

10.1001/archpsyc.1979.01780110017001

Koda, 1971, The effect of repeated large doses of methamphetamine on adrenal and brain tyrosine hydroxylase, Pharmacologist, 13, 253

Perez-Rincon, 1981, Nomifensine in the treatment of depression: A long term controlled trial, Current Therapeutic Research-Clinical Experimental, 29, 327

10.1016/0014-2999(76)90352-6

10.1523/JNEUROSCI.03-08-01607.1983

10.1093/schbul/5.3.460

Solomon, 1982, Differential effects of micro injections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus, Biological Psychiatry, 17, 743

10.1126/science.2878495

Jimerson, 1984, Neurobiology of mood disorders

Zemlan, 1984, Proceedings of the American College of Neuropsychology

10.1016/0091-3057(86)90532-0

Fallon, Monoamines in the cerebral cortex and a theory on the functions of monoamines in cortex and basal ganglia, Cerebral cortex, 6

10.1016/0006-8993(77)90423-1

Rolls, 1984, The basal ganglia: Structure and function

10.1007/BF00439110

10.1016/0014-2999(83)90408-9

10.1037/0033-295X.91.2.251

10.1016/0024-3205(84)90147-4

10.1016/S0166-2236(84)80145-9

10.1016/0166-4328(86)90086-0

Dement, 1968, Some parallel findings in schizophrenic patients and serotonindepleted cats, Psychophysiology, 5, 239

10.1038/274897a0

10.1113/jphysiol.1970.sp009143

10.1016/S0074-7742(08)60628-5

Tassin, 1987, Further evidence for cortico-subcortical relationships

10.1001/archpsyc.1986.01800020042006

10.1146/annurev.ps.31.020180.001421

10.1016/0006-8993(85)90140-4

10.1007/BF00555222

10.1016/0166-2236(81)90039-4

10.1016/0166-2236(86)90145-1

10.1038/284265a0

10.1016/0361-9230(85)90089-9

Gruenthal, 1980, The effect of lithium administration on apomorphineinduced rotation following unilateral destruction of the nigrostriatal pathway in the rat, Society of Neurosdence Abstracts, 6, 546

Klerman, 1965, Clinical pharmacology of imipramine and related antidepressant compounds, Pharmacology Review, 17, 101

Christie M. J. , Summers R. J. , Stephenson J. A. , Cook C. J. & Beart P. M. (in press) Excitatory amino acid projections in the rat brain. 1. Nucleus accumbens septi: A retrograde transport study utilizing D[3H]aspartate and [3H]GABA. Neuroscience. [PMB]

10.1001/archpsyc.1984.01790170081009

10.1001/archpsyc.1982.04290090001001

10.1016/S0140-6736(87)90002-X

10.1007/BF00421073

Sulser, 1980, Typical and atypical antidepressants: Molecular mechanisms

10.1007/BF00427605

Gray, 1975, Elements of a two-process theory of learning

10.1016/0006-8993(78)90197-X

10.1017/S0140525X00010372

Scheel-Kruger, 1983, GABA receptors

10.1016/0006-3223(85)90024-1

10.1016/0278-5846(83)90025-8

10.1038/305527a0

Gold, 1986, Mesolimbic dopamine lesions block the unconditioned and conditioned motor effects of amphetamine, Neuroscience Abstracts, 12, 1137

10.1016/0006-8993(84)91117-X

10.1038/286074a0

Bank, 1986, Effects of NMR conditioning on intracellular distribution of protein kinase C, Society for Neurosdence Abstracts, 1, 182

10.1016/0014-2999(79)90366-2

Gray, 1987, The psychology of fear and stress

10.1016/0006-8993(75)90233-4

10.1097/00004714-198107000-00003

Matthysse, 1973, Antipsychotic drug actions: A clue to the neuropathology of schizophrenia?, Federation Proceedings, 32, 200

10.1111/j.2042-7158.1980.tb13033.x

Ballenger, 1980, Carbamazepine in manic-depressive illness: A new treatment, American Journal of Psychiatry, 137, 782, 10.1176/ajp.137.7.782

Herve, 1983, Effects of electroconvulsive therapy on mood, parkinsonism and tardive dyskinesia in a depressed patient: ECT and dopamine systems, Biological Psychiatry, 18, 865

10.1001/archpsyc.1983.01790050041005

10.1016/0006-8993(85)90530-X

10.1176/ajp.128.10.1239

10.1016/0022-3956(71)90017-3

10.1016/0301-0082(86)90010-9

Breier, 1986, Negative and positive symptoms of schizophrenia: Pharmacologic and etiologic considerations. Presented at the Society of Biological Psychiatry, May 1986

10.1016/0278-5846(83)90112-4

Siggins, 1978, Psychopharmacology: A generation of progress

10.1001/archpsyc.1974.01760130034005

10.1007/BF00174372

King, 1985, Emotion: Theory, research and experience, 3

10.1016/0006-8993(83)90882-X

10.1037/h0077542

10.1002/mds.870010102

10.1016/0006-8993(86)91534-9

Cools, 1980, The basal ganglia

Bartholini, 1981, GABA and the basal ganglia

Hornykiewicz, 1963, Die topische localisation das verhalten von noradrenalin und dopamin (3-hydroxytyramin) in der substantia nigra des normalen und Parkinson-kranken menschen, Wiener Klinische Wochenschrift, 57, 309

10.1176/ajp.122.5.509

Juhl, 1977, Concomitant administration of haloperidol and lithium carbonate in acute mania, Diseases of the Nervous System, 38, 675

10.1212/WNL.28.1.36

10.1016/0166-2236(83)90069-3

10.1001/archpsyc.1982.04290070025006

10.1016/0149-7634(85)90004-1

Grace, 1986, Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: Analysis using in vivo intracellular recording, Journal of Pharmacology and Experimental Therapeutics, 238, 1092

10.1136/bmj.3.5670.564

10.1001/archpsyc.1986.01800020020004

10.1016/S0163-1047(80)93132-5

Gray, 1969, Animal discrimination learning

10.1016/0006-8993(82)90685-0

10.1007/BF00433801

10.1016/0165-1781(86)90102-2

Akert, 1964, The frontal and granular cortex and behaviour

Seligman, 1975, Helplessness; On depression, development, and death

10.1016/0031-9384(69)90156-5

Van Woert M. H. , Ambani L. & Bowers M. B. Jr , (1972) Levodopa and eholinergic hypersensitivity in Parkinson's disease. Neurology (supplement) 86–93. [rNRS]

10.1017/S0317167100046217

Bloom, 1965, Anesthesia and the responsiveness of individual neurons of the caudate nucleus of the cat to acetylcholine, norepinephrine and dopamine administered by microelectrophoresis, Journal of Pharmacology and Experimental Therapeutics, 150, 244

Chute, 1985, Intracellular biochemical events and mammalian behavior. Presented at the 4th World Congress of Biological Psychiatry

10.1038/299484a0

Kety, 1970, Current biochemical research in schizophrenia, Psychopathology of schizophrenia

10.1016/0306-4522(82)90067-7

10.1001/archpsyc.1973.04200020023003

Baldessarini, 1977, Chemotherapy in psychiatry

10.1016/0006-8993(69)90141-3

10.1016/0024-3205(82)90295-8

10.1007/BF00432676

Shelton, 1986, The neurology of schizophrenia

10.1038/311461a0

Fallon, 1983, The islands of Calleja complex of rat basal forebrain. III. Histochemical evidence for a striatopallidal system, Journal of Comparative Neuroscience, 16, 19

Pitman, 1987, Ethological study of facial behavior in nonparanoid and paranoid schizophrenics, American Journal of Psychiatry, 144, 99, 10.1176/ajp.144.1.99

10.1073/pnas.77.4.2323

10.1007/BF00429010

10.1016/0006-2952(75)90412-8

Rolls, 1982, Neural activity in the ventral striatum of the behaving monkey, Proceedings of the Society of Neuroscience, 8, 169

10.1111/j.1471-4159.1983.tb12685.x

Crawley, 1985, Cholecystokinin potentiates dopamine-mediated behaviors: Evidence for modulation specific to a site of coexistence, Journal of Neuroscience Research, 5, 1972, 10.1523/JNEUROSCI.05-08-01972.1985

10.1016/0024-3205(74)90516-5

Bannon, 1983, Pharmacology of mesocortical dopamine neurons, Pharmacological Reviews, 35, 53

Weinberger, 1986, Dopamine and human cognition: rCBF studies in Parkinson's disease, Neuroscience Abstracts, 12, 1142

Sitaram, 1984, Neurobiology of mood disorders

10.1126/science.566468

10.1002/cne.902140206

10.1007/BF00310514

10.1016/0306-4522(85)90272-6

Cunne, 1972, Clinical trials with amphetamine-blocking drugs, Psychiatric Neurology and Neurobiology, 75, 225

10.1007/BF00172874

10.1002/cne.902220407

Jones, 1980, Nucleus accumbens to globus pallidus GABA projection subserving ambulatory activity, American Journal of Physiology, 238, 63

10.1001/archpsyc.1981.01780350094011

Pardes, 1986, Neuroscience and psychiatry: Marriage or coexistence?, The American Journal of Psychiatry, 143, 1205, 10.1176/ajp.143.10.1205

10.1016/0013-4694(72)90045-4

Seeman, 1981, Dopamine receptors in post-mortem schizophrenic brains, Lancet, 2, 1130

Murphy, 1975, American handbook of psychiatry, 6

10.1016/0166-4328(85)90012-9

King, 1986, CSF dopamine levels correlate with extroversion in depressed patients, Psychological Research, 19, 305

10.1016/0091-3057(86)90131-0

10.1016/0006-8993(86)90989-3

10.1016/0167-0115(83)90003-4

10.1146/annurev.pa.21.040181.002041

Cools, 1984, The basal ganglia

10.1017/S0140525X00013066

Swerdlow N. R. & Koob G. F. (in press a) Supersensitive locomotor response to intraventricular norepinephrine following selective dopamine depletion from the nucleus accumbens in rats. Neuroscience Abstracts. [rNRS]

10.1001/archpsyc.1986.01800090035006

Randrup, 1975, Current developments in psychopharmacology, 2

10.1007/BF00427688

10.1016/0304-3940(83)90500-1

10.1126/science.3854

10.1093/brain/102.2.347

10.1136/jnnp.30.4.368

10.1037/10802-000

Judd, 1982, New Research Abstracts of the APA Annual Meeting

Gray, Proceedings of symposium on cognitive neurochemistry, Harlow, Essex, 1986

10.1007/BF00433564

Roth, 1979, Research in the psychobiology of human behavior

10.1016/0306-4522(84)90203-3

Coffman, 1984, Left hemispheric density deficits in chronic schizophrenia, Biological Psychiatry, 19, 1237

Schwaber, 1982, Amygdaloid and basal forebrain direct connections with the nucleus of the solitary tract and the dorsal motor nucleus, Journal of Neuroscience Research, 2, 1424, 10.1523/JNEUROSCI.02-10-01424.1982

Abrams, 1975, New dimensions in psychiatry

Adler, 1982, Biological Psychiatry, 17

10.1016/0006-3223(86)90244-1

10.1097/00005053-198508000-00009

10.1001/archpsyc.1984.01790160114018

10.1007/BF00427315

Allen, 1986, Hospital evaluation and treatment of dementia, Resident and Staff Physician, 32, 71

10.1001/jama.1985.03360150079028

1980, American Psychiatric Association

Anden, 1977, Functional effects of local injections of dopamine and analogs into the neostriatum and nucleus accumbens, Advances in Biochemical Psychopharmacology, 16, 385

10.1007/BF00496057

10.1176/ajp.118.11.1013

Bak, 1975, Dopaminergic mechanisms

10.1146/annurev.ne.03.030180.000323

Bannon, 1981, Mesocortical dopamine neurons: Lack of autoreceptors modulating dopamine synthesis, Molectdar Pharmacology, 19, 270

10.1111/j.1476-5381.1983.tb11035.x

Wolkin, 1985, Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography, American Journal of Psychiatry, 142, 564, 10.1176/ajp.142.5.564

Zis, 1983, American Psychological Association Annual Meeting

10.1007/BF00426724

10.1002/cne.901840104

10.1016/0006-8993(82)90809-5

10.1093/schbul/9.2.213

10.1111/j.1469-8986.1978.tb01390.x

10.1016/0006-3223(87)90224-1

Bunney, 1977, A neuronal receptor sensitivity mechanism in affective illness (a review of evidence), Community Psychopharmacology, 1, 393

10.1093/schbul/5.3.453

Carlton, 1984, Analysis of physiological mechanism in psychopharmacology, Neuropsychobiology, 12, 158, 10.1159/000118131

Celesia, 1972, Psychiatric disturbances in Parkinson's diesase, Diseases of the Nervous System, 33, 577

10.1016/0006-8993(86)90976-5

10.1001/archneur.1986.00520100013007

10.1007/BF00427744

10.1136/bmj.280.6207.66

10.1016/0166-2236(82)90202-8

Crow, 1984, Catecholamines: Neuropharmacology and central nervous system-therapeutic aspects

Csernansky, 1985, Lidocaine kindling is accompanied by an increase in apomorphine stereotypy and mesolimbic dopamine D2 receptor density, Psychopharmacology Bulletin, 21, 707

D'Agata, 1979, Neuroendocrine correlates in neurology and psychiatry

10.1097/00005053-198307000-00008

10.1007/BF01243275

Davis, 1978, The nature of schizophrenia

10.1176/ajp.128.10.1303

10.1037/h0081662

10.1016/0006-8993(73)90154-6

10.1016/0006-3223(86)90243-X

10.1001/archpsyc.1984.01790140083010

Kita, 1985, Regenerative potentials in rat neostriatal neurons in an in vitro slice preparation, Experimental Brain Research, 60, 63

Fibiger, 1986, Reward, motivation and cognition: Psychobiology of meso-telencephalic dopamine systems, Handbook of physiology: The nervous system, 4

Fibiger, 1987, Brain reward systems and abuse

10.1192/bjp.113.504.1237

10.1136/jnnp.48.6.517

10.1016/0306-4522(81)90168-8

10.1016/0022-3956(75)90027-8

10.1111/j.1749-6632.1986.tb21502.x

10.1038/194897b0

10.3758/BF03336682

10.1016/0006-8993(85)91581-1

Gray, 1972, Physiology, emotion and psychosomatic illness

Gray, 1982, The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system

Cools, 1985, Perspectives in Ethology 6 (Mechanisms)

Poncelet M. , Dangoumau L. , Soubrié P. & Simon P. (in press) Effects of neuroleptic drugs, clonidine and lithium on the expression of conditioned behavioral excitation in rats. Psychopharmacology. [PS]

Gray, 1985, Anxiety and the anxiety disorders

Heimer, 1975, Colgi centennial symposium proceedings

10.1016/0304-3940(81)90157-9

Holcomb, 1983, Effects of electroconvulsive therapy on mood, parkinsonism and tardive dyskinesia in a depressed patient: ECT and dopamine systems, Biological Psychiatry, 18, 865

10.1016/S0140-6736(72)93021-8

10.1016/0166-4328(84)90016-0

10.1212/WNL.30.12.1326

John E. R. (1986) Personal communication. [AW]

10.1037/0735-7044.99.3.531

10.1016/0166-4328(80)90043-1

Kleinman, 1986, The neurology of schizophrenia

10.1016/0006-8993(76)90478-9

10.1001/archpsyc.1976.01770120029002

Kornetsky, 1979, Euphorigenic drugs: Effects on reward pathways of the brain, Federal Proceedings, 38, 2473

10.1016/0022-3956(84)90046-3

10.1113/jphysiol.1981.sp013764

10.1016/0006-8993(85)91104-7

10.1037/h0034425

Lyon, 1975, Current developments in psychopharmacology, 2

10.1016/0166-2236(80)90103-4

Marsden, 1984, Functions of the basal ganglia, 107

10.1001/archpsyc.1984.01790190090012

10.1113/jphysiol.1967.sp008175

10.1136/jnnp.33.2.188

10.1016/0301-0082(80)90018-0

10.1016/0361-9230(83)90166-1

Mogenson, 1983, Neural projections fron the nucleus accumbens to globus pallidus, substantia innominata, and lateral preoptic-lateral hypothalamic area: An anatomical and electrophysiological investigation in the rat, Journal of Neuroscience Research, 3, 189, 10.1523/JNEUROSCI.03-01-00189.1983

10.1111/j.1600-0447.1985.tb05055.x

10.1038/229135a0

Foane, The limbic system: Functional organization and clinical disorders

10.1016/0306-4522(78)90041-6

10.1001/archpsyc.1979.01780090013001

10.1016/0006-8993(81)90693-4

10.1146/annurev.ne.06.030183.000445

10.1056/NEJM197302152880703

Pert, 1982, Basic mechanisms in the action of lithium

10.1007/BF00427441

10.1001/archpsyc.1978.01770310017001

10.1016/0014-2999(84)90403-5

Porsolt, 1981, Antidepressants: Neurochemical, behavioural and clinical perspectives

10.1016/0014-2999(78)90118-8

10.1016/0165-0173(83)90007-3

10.1038/266730a0

Franks, 1983, Neurophysiological studies of sensory gating in mania: Comparison with schizophrenia, Biological Psychiatry, 18, 989

10.1007/BF00431272

10.1111/j.1471-4159.1980.tb04625.x

10.1001/archpsyc.1979.01780070027003

10.1007/BF00427680

10.1038/285409a0

10.1016/0091-3057(77)90084-3

10.1016/0091-3057(80)90166-5

Scheel-Kruger, 1986, Dopamine-GABA interactions: Evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system, Acta Neurologica Scandinavica, 73, 107

Schildkraut, 1970, Neuropsychopharmacology and the affective disorders

10.1016/0021-9681(58)90006-7

10.1016/0165-0173(83)90011-5

10.1126/science.6147018

10.1212/WNL.35.10.1506

10.1001/archpsyc.1966.01730110013003

10.1002/cne.901670207

10.1016/0006-8993(75)90278-4

10.1002/cne.901630406

10.1016/0006-3223(86)90005-3

10.1016/0024-3205(84)90440-5

10.1016/0091-3057(85)90574-X

Swerdlow N. R. & Koob G. F. (in press b) Lesions of the dorsomedial nucleus of the thalamus, medial prefrontal cortex and pedunculopontine nucleus: Effects on locomotor activity mediated by nucleus accumbensventral pallidal circuitry. Brain Research.[rNRS]

Swerdlow, 1985, The effects of chronic dietary lithium on behavioral indices of dopamine denervation supersensitivity in the rat, Journal of Pharmacology and Experimental Therapeutics, 235, 324

Hollister, 1978, Clinical pharmacology: Basic prindples in therapeutics

10.1016/0166-2236(86)90169-4

10.1016/0304-3940(84)90351-3

10.1038/jcbfm.1986.77

10.1007/BF00429734

Whishaw, 1983, Behavioral approaches to brain research

10.1001/archpsyc.1981.01780280046004

10.1016/0006-8993(78)90253-6

10.1001/archpsyc.1985.01790260086010

10.1016/0278-5846(86)90057-6

10.1007/BF00496868

10.1016/0006-8993(81)90784-8

10.1212/WNL.35.8.1215

10.1038/273309a0

10.1159/000123454

Ingvar, 1974, Distribution of cerebral activity in chronic schizophrenia, Lancet, 2, 1481

Braff, 1986, Sensory gating deficits in rat acoustic startle: Effects of psychostimulants

10.1001/archpsyc.1971.01750090021003

10.1016/0006-8993(86)90006-5

Mattes, 1985, A high dose double-blind study of ceruletide in the treatment of schizophrenia, American Journal of Psychiatry, 142, 1482, 10.1176/ajp.142.12.1482

10.1016/0306-4522(84)90014-9

10.1016/0278-5846(83)90110-0

10.1016/0006-8993(76)90509-6

10.1016/0306-4530(77)90046-4

Solomon, 1981, Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced super-sensitivity-relationship to schizophrenic attention disorder, Biological Psychiatry, 16, 519

10.1016/0024-3205(78)90471-X

Beart, 1986, Excitatory amino acid transmission

10.1037/h0046200

10.1016/0006-8993(67)90091-1

Shelton R. C. , Doran A. J. , Pickar D. & Weinberger D. R. (1985) Cerebral structural pathology in schizophrenia: A new cohort. Abstracts: Proceedings of the World Congress of Biological Psychiatry, Philadelphia, 09. [GEJ]

Kupfer, 1972, Hypersomnia in manic depressive disease, Disorders of the Nervous System, 33, 720

Taghzouti K. , Tassin J. P. & Simon H. (submitted) Bilateral injections of 6-OHDA in the amygdala provoke opposite changes of DA utilization in the nucleus accumbens and the prefrontal cortex. Relationship with amphetamine-induced locomotor hyperactivity. [JPT]

Crow, 1981, Biological psychiatry

10.1016/0014-2999(85)90219-5

10.1016/0091-3057(86)90261-3

10.1016/0006-3223(85)90151-9

10.1016/0006-8993(82)90282-7

Lee, 1977, Dopamine receptors in normal and schizophrenic human brains, Society of Neuroscience Abstracts, 3, 443

10.1007/BF00690931

10.1016/0022-3956(84)90047-5

10.1111/j.1471-4159.1979.tb04533.x

10.1212/WNL.37.1.42

10.1001/archpsyc.1965.01730060001001

10.1001/archneurpsyc.1922.02190120032002

Bruyn, 1968, Handbook of clinical neurology

10.1126/science.171.3975.1032

10.1002/cne.901800105

10.1016/0091-3057(82)90451-8

10.1111/j.1600-0447.1981.tb00694.x

10.1016/0006-8993(77)90430-9

10.1016/0006-8993(80)91217-2

10.1016/0306-4522(82)90198-1

10.1001/archpsyc.1975.01760250055005

10.1016/0165-1781(83)90106-3

Tassin, 1986, Long-term receptor regulation induced by denervation of heterologous afferent fibers: Functional significance

10.1001/archpsyc.1985.01790280019002

Alheid, 1985, The ventral-striato-pallidal (VSP) system and the substantia innominate (SI) complex of the rat. Abstract presented at Symposium: The neural and metabolic bases of feeding, Appetite, 6, 198

10.1001/archpsyc.1972.01750260021004

10.1016/0006-8993(78)90634-0

10.1007/BF01921907

10.1007/BF00426896

10.1016/0028-3908(82)90096-X

10.1093/brain/93.4.793

10.1016/0306-4522(82)90161-0

10.1126/science.1111112

10.1126/science.6334362

10.1016/0306-4522(78)90063-5

10.1016/0306-4522(80)90127-X

Post, 1982, Symposium on special aspects of psychopharmacology

10.1016/0196-9781(81)90062-0

10.1001/archpsyc.1973.04200040066011

10.1097/00005053-197210000-00007

Carter, 1980, Glutamergic pathways from the medial prefrontal cortex to the anterior striatum, nucleus accumbens and substantia nigra, British Journal of Pharmacology, 70, 50P

Redmond, 1979, Phenomenology and treatment of anxiety

10.1016/0006-8993(85)90215-X

10.1007/BF00428696

10.1001/archpsyc.1984.01790170091010

10.1136/jnnp.47.5.443

10.1016/S0166-2236(84)80254-4

Goodwin, 1970, L-Dopa, catecholamines, and behavior: A clinical and biochemical study in depressed patients, Biological Psychiatry, 2, 341

10.1001/archpsyc.1981.01780340066008

Nelson, 1983, The symptoms of major depressive illness, American Journal of Psychiatry, 138, 1

10.1007/BF00235003

10.1016/0361-9230(84)90189-8

10.1016/0166-2236(82)90037-6

10.1002/cne.902230303

Heimer, 1985, The rat nervous system, 1